Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer.
Physicians respond to a positive fecal occult blood test with a variety of workup strategies. To study the effect of the choice of strategy on the net costs and health benefits of colorectal cancer screening using this test, we used a decision analysis model to compare seven strategies that physicians might choose to examine a positive "screenee." Strategies using rigid or flexible sigmoidoscopy alone are not only insensitive, but also have high cost-effectiveness ratios. The strategy of air contrast barium enema alone had the lowest cost-effectiveness ratio. Rigid sigmoidoscopy combined with barium enema had a lower cost-effectiveness ratio than primary colonoscopy, but the strategy of primary colonoscopy could have an equal or better ratio depending on assumptions about test costs and the benefit of removing benign polyps. The primary colonoscopy strategy is both more effective and less costly than the combination of flexible sigmoidoscopy and barium enema. The optimal strategy will vary with local factors, and with the perspective of the decision-maker.
D000368:Aged; D001466:Barium Sulfate; D003110:Colonic Neoplasms / Q000517:prevention & control*; D003113:Colonoscopy / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D009780:Occult Blood / Q000191:economics* / Q000379:methods; D012004:Rectal Neoplasms / Q000517:prevention & control*; D012812:Sigmoidoscopy / Q000191:economics
D001466:Barium Sulfate